Literature DB >> 7661204

Role of the completion phenomenon in the evaluation of Amsler grid results.

O A Achard1, A B Safran, F C Duret, E Ragama.   

Abstract

PURPOSE: To evaluate the limitations, particularly those related to the perceptual completion phenomenon, of Amsler grid tests in patients with central scotomas caused by macular disorders.
METHODS: We tested 15 affected eyes of 15 patients with macular lesions. In each subject, the central visual field was assessed by using four different types of Amsler grid testing and a tangent screen. Tests were conducted in a random order, and the sequence of tests was repeated once. The distance between the fixation point and the closet border of the plotted scotoma was assessed. For each patient, reproducibility in repeated examinations was evaluated by assessing changes in location of the computed center of the defects and by measuring changes in the position of the center of the scotoma.
RESULTS: The tangent screen was more sensitive than Amsler grids in delineating the borders of the scotoma, and the results were more reproducible. Furthermore, by using a tangent screen, the fixation point was found adjacent to the scotoma.
CONCLUSION: Poor sensitivity and intraindividual variations found with Amsler grid testing are at least partly a result of the perceptual completion phenomenon. This phenomenon proved to be a dynamic and fluctuating process, as the results of two successive Amsler grid tests were not comparable, even when the technique was identical and the time between tests was no more than two to 15 minutes.

Entities:  

Mesh:

Year:  1995        PMID: 7661204     DOI: 10.1016/s0002-9394(14)72162-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Fixation locus in patients with bilateral central scotomas for targets that perceptually fill in.

Authors:  Joshua D Pratt; Joy M Ohara; Stanley Y Woo; Harold E Bedell
Journal:  Optom Vis Sci       Date:  2014-03       Impact factor: 1.973

2.  The "thin man" phenomenon: a sign of cortical plasticity following inferior homonymous paracentral scotomas.

Authors:  A B Safran; O Achard; F Duret; T Landis
Journal:  Br J Ophthalmol       Date:  1999-02       Impact factor: 4.638

3.  Scotoma Visibility and Reading Rate with Bilateral Central Scotomas.

Authors:  Joshua D Pratt; Scott B Stevenson; Harold E Bedell
Journal:  Optom Vis Sci       Date:  2017-03       Impact factor: 1.973

4.  Environmental Amsler test as a monitoring tool for retreatment with ranibizumab for neovascular age-related macular degeneration.

Authors:  R Mathew; S Sivaprasad
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

5.  Metamorphopsia in patients with macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Frank G Holz; Hendrik P N Scholl
Journal:  Doc Ophthalmol       Date:  2009-08-27       Impact factor: 2.379

6.  Orientation discrimination with macular changes associated with early AMD.

Authors:  Harold E Bedell; Jianliang Tong; Stanley Y Woo; Jon R House; Tammy Nguyen
Journal:  Optom Vis Sci       Date:  2009-05       Impact factor: 1.973

7.  Filling-in phenomenon in patients with age-related macular degeneration: differences regarding uni- or bilaterality of central scotoma.

Authors:  Salomon Yves Cohen; Frédéric Lamarque; Jeanne-Claude Saucet; Pierre Provent; Cecilia Langram; Jean-François LeGargasson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-20       Impact factor: 3.117

8.  Improved Adherence to Vision Self-monitoring with the Vision and Memory Stimulating (VMS) Journal for Non-neovascular Age-related Macular Degeneration during a Randomized Controlled Trial.

Authors:  Ava K Bittner; Sheryl Torr-Brown; Ellen Arnold; Antonia Nwankwo; Patricia Beaton; Radhika Rampat; Gislin Dagnelie; Mark Roser
Journal:  J Clin Exp Ophthalmol       Date:  2014-01-22

Review 9.  Early detection of age related macular degeneration: current status.

Authors:  Roy Schwartz; Anat Loewenstein
Journal:  Int J Retina Vitreous       Date:  2015-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.